Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07814859
What this trial is testing

Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital of Zhengzhou University 88
Not applicableLooking for participantsNCT06102759
What this trial is testing

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04169997
What this trial is testing

IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Impact Therapeutics, Inc. 404
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07148427
What this trial is testing

Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00242788
What this trial is testing

IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

Who this might be right for
Colorectal Cancer
AstraZeneca 40
Testing effectiveness (Phase 2)UnknownNCT02930954
What this trial is testing

Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance

Who this might be right for
Non-small-cell Lung Cancer
Caicun Zhou 180
Testing effectiveness (Phase 2)UnknownNCT05760053
What this trial is testing

Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma

Who this might be right for
ToripalimabFirst-line Treatment
Sun Yat-sen University 33
Testing effectiveness (Phase 2)Ended earlyNCT01038037
What this trial is testing

First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Vejle Hospital 23
Testing effectiveness (Phase 2)Study completedNCT01921673
What this trial is testing

Dovitinib Plus Docetaxel in Gastric Cancer

Who this might be right for
Gastric Cancer
Asan Medical Center 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06050941
What this trial is testing

Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
First Affiliated Hospital of Zhejiang University 60
Large-scale testing (Phase 3)UnknownNCT05446883
What this trial is testing

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
METASTATIC CERVICAL CANCER
Qilu Pharmaceutical Co., Ltd. 498
Large-scale testing (Phase 3)Looking for participantsNCT05918094
What this trial is testing

Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Sun Yat-sen University 540
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294
What this trial is testing

Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 294
Testing effectiveness (Phase 2)UnknownNCT05930665
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Sun Yat-sen University 38
Testing effectiveness (Phase 2)Study completedNCT06375707
What this trial is testing

First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 74
Testing effectiveness (Phase 2)UnknownNCT05030077
What this trial is testing

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaAnlotinibUrogenital Neoplasms+4 more
Tianjin Medical University Second Hospital 53
Testing effectiveness (Phase 2)Study completedNCT05673577
What this trial is testing

Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Fudan University 41
Post-approval studies (Phase 4)WithdrawnNCT00510627
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Who this might be right for
Metastatic Liver CancerSecondary Liver CancerLiver Neoplasm
Boston Scientific Corporation
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07229846
What this trial is testing

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Who this might be right for
Colorectal Cancer
Yanqiao Zhang 30
Testing effectiveness (Phase 2)UnknownNCT05429294
What this trial is testing

Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038

Who this might be right for
HER2-positive Breast Cancer
First Affiliated Hospital Xi'an Jiaotong University 209
Next Page